Dose Escalation Study of CLR 131 in Children and Adolescents With Relapsed or Refractory Malignant Tumors Including But Not Limited to Neuroblastoma, Rhabdomyosarcoma, Ewings Sarcoma, and Osteosarcoma (CLOVER-2)

The study evaluates CLR 131 in children and adolescents with relapsed or refractory malignant solid tumors and lymphoma and recurrent or refractory malignant brain tumors for which there are no standard treatment options with curative potential.

NCT: NCT03478462

Locations: University of Wisconsin Hospital and Clinics

Link: https://clinicaltrials.gov/ct2/show/NCT03478462?recrs=ad&cond=Neuroblastoma&locn=University+of+Wisconsin&cntry=US&age=0&draw=2&rank=2